Effect of naloxone on plasma adrenocorticotropin levels and beta-endorphin-like immunoreactivity in bilaterally adrenalectomized patients with Cushing's disease and in Addison's disease.
Kasperlik-Załuska
A
A
Jeske
W
W
Migdalska
B
B
Soszyński
P
P
Wiśniewska-Woźniak
T
T
D000224:Addison Disease / Q000097:blood*; D000315:Adrenalectomy; D000324:Adrenocorticotropic Hormone / Q000097:blood*; D000328:Adult; D003480:Cushing Syndrome / Q000097:blood* / Q000503:physiopathology; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009270:Naloxone / Q000008:administration & dosage*; D011863:Radioimmunoassay; D001615:beta-Endorphin / Q000097:blood*
D009270:Naloxone; D001615:beta-Endorphin; D000324:Adrenocorticotropic Hormone